A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo

Study Title
A Phase 1b, Open-Label Trial to Assess Safety and Exploratory Efficacy of TEV-53408 in Participants With Vitiligo
Teva Identifier
TV53408-IMM-10209
ClinicalTrials.gov Identifier
NCT06625177
Study Status
Recruiting
Trial Condition(s)
Vitiligo
Interventions
Drug: TEV-53408
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
allergy-icon

Key Participation Requirements

Gender
Female, Male
Age group
Adult, Older Adult
Age Range
18 Years to 75 Years
Trial Duration
November 11, 2024 - January 31, 2029
Phase
Phase 1

Study Type

Interventional